Analysis

Kalaris Therapeutics, Inc. (KLRS) Stock Analysis

Kalaris Therapeutics, Inc. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysis connected to KLRS.

websiteKLRS/analysis/KLRS

Kalaris Therapeutics, Inc.

Kalaris Therapeutics, Inc. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysisconnected to KLRS.

Stock profile

Ticker

KLRS

Asset type

Stock

Market cap

$103.0M

Sector

Health Technology

Industry

Biotechnology

Currency

USD

Ticker listings

Kalaris Therapeutics, Inc. may appear across multiple exchanges or ticker formats. 6ix consolidates those listings around the canonical analysis page for discovery.

  • KLRS primary listing

Latest Kalaris Therapeutics, Inc. news

Kalaris to Present at Clinical Trials at the Summit 2026

Kalaris to Present at Clinical Trials at the Summit 2026

Kalaris Reports First Quarter 2026 Financial Results and Provides Business Updates

Patient screening now underway in the Phase 1b/2 study with the latest drug product batch on track to be available to support upcoming dosing; preliminary data anticipated in 1H...

Kalaris Reports Full Year 2025 Financial Results and Provides Business Updates

Positive initial data reported from Phase 1a Single Ascending Dose study in nAMD in December 2025; preliminary data from ongoing Phase 1b/2 study expected in

Kalaris to Present Phase 1 Clinical Data for TH103 at the Macula Society Annual Meeting

BERKELEY HEIGHTS, N.J., Jan. 28, 2026 (GLOBE NEWSWIRE) -- Kalaris Therapeutics, Inc. (NASDAQ: KLRS) (“Kalaris”), a clinical-stage biopharmaceutical company developing differenti...

Kalaris Therapeutics Announces Oversubscribed $50.0 Million Private Placement

BERKELEY HEIGHTS, N.J., Dec. 17, 2025 (GLOBE NEWSWIRE) -- Kalaris Therapeutics, Inc. (NASDAQ: KLRS) (“Kalaris”), a clinical-stage biopharmaceutical company dedicated to the deve...

Research sections

Valuation

Review valuation context for Kalaris Therapeutics, Inc..

Future growth

Review future growth context for Kalaris Therapeutics, Inc..

Past performance

Review past performance context for Kalaris Therapeutics, Inc..

Financial health

Review financial health context for Kalaris Therapeutics, Inc..

Dividend

Review dividend context for Kalaris Therapeutics, Inc..

Management

Review management context for Kalaris Therapeutics, Inc..

Ownership

Review ownership context for Kalaris Therapeutics, Inc..

Other information

Review other information context for Kalaris Therapeutics, Inc..

Community

Review community context for Kalaris Therapeutics, Inc..